Sharescart Research Club logo ×
Screener Research Unlisted Startup Funding New IPO New

  • Home
  • /
  • Brawn Biotech
Join Channel
Consolidated Standalone

Brawn Biotech

₹27.5 0 | 0%

Market Cap ₹8 Cr.

Stock P/E -10.1

P/B 1.4

Current Price ₹27.5

Book Value ₹ 19

Face Value 10

52W High ₹27.5

Dividend Yield 0%

52W Low ₹ 14.4

Edit Ratio

Brawn Biotech Research see more...

Overview Inc. Year: 1985Industry: Trading

Brawn Biotech Share Price

New

₹ | |

Volume
Price

Quarterly Price

Quarterly Monthly
Show Value Show %

Peer Comparison

Brawn Biotech Quarterly Results

#(Fig in Cr.) Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Jun 2023 Sep 2023
Net Sales 15 3 1 2 3 3 3 8 7 3
Other Income 0 0 0 0 0 -0 0 0 0 0
Total Income 15 3 1 2 3 3 3 8 7 3
Total Expenditure 15 4 1 3 4 3 3 8 7 3
Operating Profit 0 -0 -0 -0 -2 0 0 -0 -0 -0
Interest 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 0 -0 -0 -0 -2 0 0 -0 -0 -0
Provision for Tax 0 0 0 0 0 -0 0 -0 0 0
Profit After Tax 0 -1 -0 -0 -2 1 0 -0 -0 -0
Adjustments 0 0 0 0 0 0 0 0 0 -0
Profit After Adjustments 0 -1 -0 -0 -2 1 0 -0 -0 -0
Adjusted Earnings Per Share 0.6 -2 -0.7 -1.6 -5.2 2.1 0.4 -1.2 -0.6 -1.4

Brawn Biotech Profit & Loss

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 TTM
Net Sales 26 38 39 47 61 56 65 50 35 9 22 21
Other Income 0 1 0 0 1 0 1 0 0 0 0 0
Total Income 26 38 39 47 61 56 66 50 35 9 22 21
Total Expenditure 25 37 38 45 59 54 64 49 36 11 23 21
Operating Profit 1 1 1 1 2 2 2 1 -0 -2 -0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
Exceptional Income / Expenses 0 -1 0 0 0 0 0 0 0 0 0 0
Profit Before Tax 1 0 0 1 2 2 2 1 -0 -2 -0 0
Provision for Tax 0 0 0 0 0 1 0 0 0 -0 0 0
Profit After Tax 0 0 0 1 1 1 1 1 -1 -2 -1 0
Adjustments 0 0 0 0 0 0 0 0 0 0 -0 0
Profit After Adjustments 0 0 0 1 1 1 1 1 -0 -2 -1 0
Adjusted Earnings Per Share 1.2 0.5 0.9 3.2 4.6 4.3 4.4 2 -1.8 -5.5 -2.9 -2.8

Growth Rates

# 1 Year 3 Year 5 Year 10 Year
Sales CAGR 144% -24% -17% -2%
Operating Profit CAGR 0% -100% -100% -100%
PAT CAGR 0% NAN% NAN% 0%
# 1 Year 3 Year 5 Year 10 Year
Share Price CAGR 59% -5% -7% 18%
ROE Average -13% -13% -3% 5%
ROCE Average -6% -12% -0% 11%

Brawn Biotech Balance Sheet

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Shareholder's Funds 5 5 5 6 7 8 9 9 9 7 6
Minority's Interest 0 0 0 0 0 0 0 0 0 0 0
Borrowings 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Liabilities 0 0 0 0 0 0 0 0 0 -0 0
Total Current Liabilities 9 9 9 8 10 15 14 11 5 6 8
Total Liabilities 14 14 14 14 17 22 22 20 14 13 14
Fixed Assets 0 0 0 0 0 0 0 0 0 0 0
Other Non-Current Assets 4 3 3 3 0 1 1 1 1 1 1
Total Current Assets 10 11 11 11 17 22 22 19 13 12 13
Total Assets 14 14 14 14 17 22 22 20 14 13 14

Brawn Biotech Cash Flow

#(Fig in Cr.) Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Opening Cash & Cash Equivalents 0 0 0 0 0 2 0 1 0 0 0
Cash Flow from Operating Activities 0 0 0 0 1 -2 0 -0 0 0 0
Cash Flow from Investing Activities -0 -0 -0 -0 1 -0 -0 -0 0 -0 -0
Cash Flow from Financing Activities -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
Net Cash Inflow / Outflow -0 0 0 -0 2 -2 0 -0 -0 -0 0
Closing Cash & Cash Equivalent 0 0 0 0 2 0 1 0 0 0 0

Brawn Biotech Ratios

# Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Earnings Per Share (Rs) 1.17 0.48 0.95 3.17 4.64 4.27 4.44 1.97 -1.84 -5.48 -2.89
CEPS(Rs) 1.22 0.53 1.03 3.28 4.75 4.38 4.55 2.09 -1.72 -5.3 -2.53
DPS(Rs) 0 0 0 1 1.5 1 0 0 0 0 0
Book NAV/Share(Rs) 15.12 15.6 16.46 18.42 23.06 25.43 28.85 30.87 29.31 24.07 21.03
Core EBITDA Margin(%) 2.43 1.19 1.44 3.06 2.04 3.51 1.79 1.48 -1.71 -23.26 -1.36
EBIT Margin(%) 2.52 0.99 1.51 3.01 3.01 3.62 2.88 1.76 -0.92 -23.84 -1.81
Pre Tax Margin(%) 2.21 0.61 1.24 2.78 2.9 3.52 2.77 1.65 -1.03 -24.57 -1.85
PAT Margin (%) 1.36 0.38 0.74 2.03 2.3 2.3 2.04 1.19 -1.57 -19.08 -3.91
Cash Profit Margin (%) 1.41 0.42 0.8 2.1 2.35 2.35 2.09 1.26 -1.48 -18.46 -3.41
ROA(%) 2.72 1.06 2.05 6.8 9.01 6.49 5.93 2.77 -3.24 -12.23 -6.31
ROE(%) 8.08 3.14 5.91 18.15 22.39 17.62 16.37 6.6 -6.1 -20.53 -12.83
ROCE(%) 14.88 8.07 11.98 26.39 29.04 27.75 23.03 9.74 -3.57 -25.66 -5.94
Receivable days 94.68 78.74 83.02 71.69 66.99 91.86 88.23 115.69 126.66 255.91 66.7
Inventory Days 30.82 15.99 12.93 5.93 2.62 2.35 1.92 2.68 3.37 105.44 78.11
Payable days 130.95 86.69 73.58 52.93 41.16 67.43 67.31 82.07 68.36 185.95 100.12
PER(x) 5.36 9.48 10.62 14.53 14.84 12.6 8.36 9.46 0 0 0
Price/Book(x) 0.42 0.29 0.61 2.5 2.99 2.12 1.29 0.6 0.75 0.72 0.79
Dividend Yield(%) 0 0 0 2.17 2.18 1.86 0 0 0 0 0
EV/Net Sales(x) 0.07 0.03 0.07 0.29 0.31 0.28 0.16 0.1 0.18 0.58 0.2
EV/Core EBITDA(x) 2.62 1.02 4.73 9.52 10.06 7.68 5.56 5.73 -21.6 -2.49 -15.45
Net Sales Growth(%) 71.84 45.92 2.31 21.31 29.14 -7.87 16.84 -23.88 -29.51 -75.35 157.88
EBIT Growth(%) 158.26 -42.81 56.44 142.2 29.3 10.6 -7.08 -53.5 -136.94 -537.7 80.43
PAT Growth(%) 1414.64 -58.94 96.51 234.06 46.66 -7.99 4 -55.64 -193.13 -198.65 47.21
EPS Growth(%) 1415.48 -58.94 96.52 234.05 46.66 -7.99 4 -55.64 -193.12 -198.64 47.21
Debt/Equity(x) 0 0 0.02 0.02 0 0 0 0 0 0 0
Current Ratio(x) 1.11 1.18 1.21 1.31 1.66 1.48 1.59 1.77 2.6 1.93 1.67
Quick Ratio(x) 0.93 0.99 1.1 1.25 1.62 1.45 1.6 1.74 2.63 1.2 1.18
Interest Cover(x) 8.26 2.62 5.58 13.24 26.47 34.97 26.65 16.61 -8.55 -32.6 -42.63
Total Debt/Mcap(x) 0.01 0 0.04 0.01 0 0 0 0 0 0 0

Brawn Biotech Shareholding Pattern

# Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024
Promoter 53.71 53.71 53.73 53.73 53.72 53.72 53.72 53.72 53.72 53.64
FII 0 0 0 0 0 0 0 0 0 0
DII 0.59 0.59 0.59 0.59 0.59 0.59 0.59 0.59 0.59 0.35
Public 45.69 45.69 45.68 45.68 45.69 45.69 45.69 45.69 45.69 46.01
Others 0 0 0 0 0 0 0 0 0 0
Total 100 100 100 100 100 100 100 100 100 100

Pros

  • Debtor days have improved from 185.95 to 100.12days.
  • Company is almost debt free.

Cons

  • Company has a low return on equity of -13% over the last 3 years.

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Brawn Biotech News

Top Unlisted Companies & InstaBuy Companies

Sell or Purchase Share (Tentative Price)

IPO

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

Companies Open Date Close Date Issue Price Cost of 1 Lot GMP Expected Listing Listing Gain(%) Listing Price Current Price Type Exchange

View more.....

You May Also Know About

Unlisted Shares Pre-IPO Shares ESOP Shares Delisted Shares

Please Login!

Click to Login
OR
Get free Account

Error!